Author:
Abdel-Misih Sherif R. Z.,Hatzaras Ioannis,Schmidt Carl,Saab Tanios-Bekaii,Klemanski Dori,Muscarella Peter,Melvin W. Scott,Ellison E. Christopher,Bloomston Mark
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.
2. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267–77.
3. The NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesTM) Pancreas Cancer (Version 1.2010). © 2010 National Comprehensive Cancer Network, Inc. Available at: NCCN.org. Accessed 3/25/2010. To view the most recent and complete version of the NCCN GuidelinesTM, go online to NCCN.org.
4. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901–8.
5. Dilhoff M, Liu J, Frankel W, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg. 2008;12(12):2171–6.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献